UniProt ID | ZN224_HUMAN | |
---|---|---|
UniProt AC | Q9NZL3 | |
Protein Name | Zinc finger protein 224 | |
Gene Name | ZNF224 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 707 | |
Subcellular Localization | Nucleus . Colocalizes with DEPDC1A at the nucleus. | |
Protein Description | May be involved in transcriptional regulation as a transcriptional repressor. The DEPDC1A-ZNF224 complex may play a critical role in bladder carcinogenesis by repressing the transcription of the A20 gene, leading to transport of NF-KB protein into the nucleus, resulting in suppression of apoptosis of bladder cancer cells.. | |
Protein Sequence | MTTFKEAMTFKDVAVVFTEEELGLLDLAQRKLYRDVMLENFRNLLSVGHQAFHRDTFHFLREEKIWMMKTAIQREGNSGDKIQTEMETVSEAGTHQEWSFQQIWEKIASDLTRSQDLMINSSQFSKEGDFPCQTEAGLSVIHTRQKSSQGNGYKPSFSDVSHFDFHQQLHSGEKSHTCDECGKNFCYISALRIHQRVHMGEKCYKCDVCGKEFSQSSHLQTHQRVHTGEKPFKCVECGKGFSRRSALNVHHKLHTGEKPYNCEECGKAFIHDSQLQEHQRIHTGEKPFKCDICGKSFCGRSRLNRHSMVHTAEKPFRCDTCDKSFRQRSALNSHRMIHTGEKPYKCEECGKGFICRRDLYTHHMVHTGEKPYNCKECGKSFRWASCLLKHQRVHSGEKPFKCEECGKGFYTNSQCYSHQRSHSGEKPYKCVECGKGYKRRLDLDFHQRVHTGEKLYNCKECGKSFSRAPCLLKHERLHSGEKPFQCEECGKRFTQNSHLHSHQRVHTGEKPYKCEKCGKGYNSKFNLDMHQKVHTGERPYNCKECGKSFGWASCLLKHQRLHSGEKPFKCEECGKRFTQNSQLHSHQRVHTGEKPYKCDECGKGFSWSSTRLTHQRRHSRETPLKCEQHGKNIVQNSFSKVQEKVHSVEKPYKCEDCGKGYNRRLNLDMHQRVHMGEKTWKCRECDMCFSQASSLRLHQNVHVGEKP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
5 | Sumoylation | ---MTTFKEAMTFKD ---CCCHHHHCCCCC | 42.33 | - | |
5 | Sumoylation | ---MTTFKEAMTFKD ---CCCHHHHCCCCC | 42.33 | - | |
18 | Phosphorylation | KDVAVVFTEEELGLL CCEEEEEEHHHHCHH | 30.77 | - | |
31 | Sumoylation | LLDLAQRKLYRDVML HHHHHHHHHHHHHHH | 37.48 | - | |
31 | Sumoylation | LLDLAQRKLYRDVML HHHHHHHHHHHHHHH | 37.48 | - | |
121 | Phosphorylation | SQDLMINSSQFSKEG CCCEECCHHHHCCCC | 18.00 | 29116813 | |
122 | Phosphorylation | QDLMINSSQFSKEGD CCEECCHHHHCCCCC | 30.65 | 29116813 | |
125 | Phosphorylation | MINSSQFSKEGDFPC ECCHHHHCCCCCCCC | 23.35 | 29116813 | |
187 | Phosphorylation | ECGKNFCYISALRIH CCCCCEEEEEHHHHH | 8.18 | 22817900 | |
204 | Phosphorylation | VHMGEKCYKCDVCGK CCCCCCEEECCCCCC | 26.22 | 22817900 | |
227 | Phosphorylation | QTHQRVHTGEKPFKC CCCCCCCCCCCCEEE | 44.15 | 23898821 | |
233 | Sumoylation | HTGEKPFKCVECGKG CCCCCCEEEEECCCC | 45.99 | - | |
233 | Sumoylation | HTGEKPFKCVECGKG CCCCCCEEEEECCCC | 45.99 | - | |
245 | Phosphorylation | GKGFSRRSALNVHHK CCCCCHHHCHHHHCC | 35.68 | 15302935 | |
255 | Phosphorylation | NVHHKLHTGEKPYNC HHHCCCCCCCCCCCH | 58.43 | 24719451 | |
258 | Sumoylation | HKLHTGEKPYNCEEC CCCCCCCCCCCHHHH | 54.89 | - | |
258 | Sumoylation | HKLHTGEKPYNCEEC CCCCCCCCCCCHHHH | 54.89 | - | |
273 | Phosphorylation | GKAFIHDSQLQEHQR HCEEECHHHHHHHCC | 20.73 | 28555341 | |
283 | Phosphorylation | QEHQRIHTGEKPFKC HHHCCCCCCCCCCCC | 44.67 | 18669648 | |
311 | Phosphorylation | NRHSMVHTAEKPFRC CCCCCCCCCCCCCCC | 25.71 | 24719451 | |
339 | Phosphorylation | NSHRMIHTGEKPYKC HCCCCEECCCCCEEC | 35.79 | 29496963 | |
342 | Ubiquitination | RMIHTGEKPYKCEEC CCEECCCCCEECCCC | 55.80 | - | |
344 | Phosphorylation | IHTGEKPYKCEECGK EECCCCCEECCCCCC | 39.06 | - | |
345 | Ubiquitination | HTGEKPYKCEECGKG ECCCCCEECCCCCCC | 43.63 | 29967540 | |
345 | Sumoylation | HTGEKPYKCEECGKG ECCCCCEECCCCCCC | 43.63 | - | |
345 | Sumoylation | HTGEKPYKCEECGKG ECCCCCEECCCCCCC | 43.63 | - | |
367 | Phosphorylation | YTHHMVHTGEKPYNC CCCCEECCCCCCCCC | 35.31 | - | |
395 | Phosphorylation | LKHQRVHSGEKPFKC HHCCCCCCCCCCCCC | 45.87 | 20068231 | |
398 | Ubiquitination | QRVHSGEKPFKCEEC CCCCCCCCCCCCCCC | 60.32 | - | |
401 | Sumoylation | HSGEKPFKCEECGKG CCCCCCCCCCCCCCC | 49.62 | - | |
401 | Sumoylation | HSGEKPFKCEECGKG CCCCCCCCCCCCCCC | 49.62 | - | |
454 | Sumoylation | QRVHTGEKLYNCKEC HHCCCCCCEECCCHH | 58.58 | - | |
454 | Sumoylation | QRVHTGEKLYNCKEC HHCCCCCCEECCCHH | 58.58 | - | |
459 | Sumoylation | GEKLYNCKECGKSFS CCCEECCCHHCCCCC | 53.02 | - | |
459 | Sumoylation | GEKLYNCKECGKSFS CCCEECCCHHCCCCC | 53.02 | - | |
466 | Phosphorylation | KECGKSFSRAPCLLK CHHCCCCCCCCCEEC | 34.32 | 17081983 | |
473 | Sumoylation | SRAPCLLKHERLHSG CCCCCEECCCHHCCC | 30.39 | 28112733 | |
473 | Sumoylation | SRAPCLLKHERLHSG CCCCCEECCCHHCCC | 30.39 | - | |
479 | Phosphorylation | LKHERLHSGEKPFQC ECCCHHCCCCCCCCC | 53.92 | 29214152 | |
507 | Phosphorylation | HSHQRVHTGEKPYKC CCCCCCCCCCCCEEC | 44.15 | 29496963 | |
510 | Sumoylation | QRVHTGEKPYKCEKC CCCCCCCCCEECCCC | 55.80 | - | |
510 | Ubiquitination | QRVHTGEKPYKCEKC CCCCCCCCCEECCCC | 55.80 | - | |
510 | Sumoylation | QRVHTGEKPYKCEKC CCCCCCCCCEECCCC | 55.80 | - | |
521 | Phosphorylation | CEKCGKGYNSKFNLD CCCCCCCCCCCCCCC | 21.54 | - | |
524 | Sumoylation | CGKGYNSKFNLDMHQ CCCCCCCCCCCCCCC | 34.33 | - | |
524 | Sumoylation | CGKGYNSKFNLDMHQ CCCCCCCCCCCCCCC | 34.33 | - | |
535 | Phosphorylation | DMHQKVHTGERPYNC CCCCCCCCCCCCCCC | 43.66 | - | |
557 | Sumoylation | GWASCLLKHQRLHSG CHHHHHHHHHHHHCC | 25.41 | - | |
557 | Sumoylation | GWASCLLKHQRLHSG CHHHHHHHHHHHHCC | 25.41 | - | |
563 | Phosphorylation | LKHQRLHSGEKPFKC HHHHHHHCCCCCCCH | 53.92 | 23401153 | |
566 | Sumoylation | QRLHSGEKPFKCEEC HHHHCCCCCCCHHHH | 60.32 | - | |
566 | Ubiquitination | QRLHSGEKPFKCEEC HHHHCCCCCCCHHHH | 60.32 | 29967540 | |
566 | Sumoylation | QRLHSGEKPFKCEEC HHHHCCCCCCCHHHH | 60.32 | - | |
566 | Acetylation | QRLHSGEKPFKCEEC HHHHCCCCCCCHHHH | 60.32 | - | |
569 | Sumoylation | HSGEKPFKCEECGKR HCCCCCCCHHHHHCE | 49.62 | - | |
569 | Sumoylation | HSGEKPFKCEECGKR HCCCCCCCHHHHHCE | 49.62 | - | |
591 | Phosphorylation | HSHQRVHTGEKPYKC CCCCCCCCCCCCEEC | 44.15 | 29496963 | |
594 | Sumoylation | QRVHTGEKPYKCDEC CCCCCCCCCEECCCC | 55.80 | - | |
594 | Ubiquitination | QRVHTGEKPYKCDEC CCCCCCCCCEECCCC | 55.80 | - | |
594 | Sumoylation | QRVHTGEKPYKCDEC CCCCCCCCCEECCCC | 55.80 | - | |
608 | Phosphorylation | CGKGFSWSSTRLTHQ CCCCCCCCHHHHHHC | 22.19 | 28555341 | |
625 | Sumoylation | HSRETPLKCEQHGKN HCCCCCCCHHHHHHH | 36.61 | 28112733 | |
625 | Sumoylation | HSRETPLKCEQHGKN HCCCCCCCHHHHHHH | 36.61 | - | |
637 | Phosphorylation | GKNIVQNSFSKVQEK HHHHHHHCHHHHHHH | 17.51 | 24719451 | |
639 | Phosphorylation | NIVQNSFSKVQEKVH HHHHHCHHHHHHHHH | 31.57 | 29978859 | |
640 | Sumoylation | IVQNSFSKVQEKVHS HHHHCHHHHHHHHHC | 46.02 | - | |
640 | Sumoylation | IVQNSFSKVQEKVHS HHHHCHHHHHHHHHC | 46.02 | - | |
640 | Acetylation | IVQNSFSKVQEKVHS HHHHCHHHHHHHHHC | 46.02 | 12430237 | |
650 | Acetylation | EKVHSVEKPYKCEDC HHHHCCCCCEECCCC | 52.03 | 12430245 | |
653 | Sumoylation | HSVEKPYKCEDCGKG HCCCCCEECCCCCCC | 39.41 | - | |
653 | Sumoylation | HSVEKPYKCEDCGKG HCCCCCEECCCCCCC | 39.41 | - | |
678 | Sumoylation | QRVHMGEKTWKCREC HCCCCCCCCEECCCC | 54.69 | - | |
678 | Sumoylation | QRVHMGEKTWKCREC HCCCCCCCCEECCCC | 54.69 | - |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of ZN224_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of ZN224_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of ZN224_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ANM5_HUMAN | PRMT5 | physical | 19741270 | |
MTUS2_HUMAN | MTUS2 | physical | 25416956 | |
PTX3_HUMAN | PTX3 | physical | 28514442 | |
LRP1B_HUMAN | LRP1B | physical | 28514442 | |
LRP4_HUMAN | LRP4 | physical | 28514442 | |
SORL_HUMAN | SORL1 | physical | 28514442 | |
ZN813_HUMAN | ZNF813 | physical | 28514442 | |
LRP2_HUMAN | LRP2 | physical | 28514442 | |
NOTC3_HUMAN | NOTCH3 | physical | 28514442 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-245, AND MASSSPECTROMETRY. |